BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19432669)

  • 1. Peroxisome proliferator-activated receptor gamma in human prostate carcinoma.
    Nakamura Y; Suzuki T; Sugawara A; Arai Y; Sasano H
    Pathol Int; 2009 May; 59(5):288-93. PubMed ID: 19432669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced beta-catenin and peroxisome proliferator-activated receptor-gamma expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome.
    Pancione M; Forte N; Sabatino L; Tomaselli E; Parente D; Febbraro A; Colantuoni V
    Hum Pathol; 2009 May; 40(5):714-25. PubMed ID: 19121846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary culture model of peroxisome proliferator-activated receptor gamma activity in prostate cancer cells.
    Xu Y; Iyengar S; Roberts RL; Shappell SB; Peehl DM
    J Cell Physiol; 2003 Jul; 196(1):131-43. PubMed ID: 12767049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor gamma expression in urothelial carcinomas of the bladder: association with differentiation, proliferation and clinical outcome.
    Mylona E; Giannopoulou I; Diamantopoulou K; Bakarakos P; Nomikos A; Zervas A; Nakopoulou L
    Eur J Surg Oncol; 2009 Feb; 35(2):197-201. PubMed ID: 18513919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor gamma is highly expressed in pancreatic cancer and is associated with shorter overall survival times.
    Kristiansen G; Jacob J; Buckendahl AC; Grützmann R; Alldinger I; Sipos B; Klöppel G; Bahra M; Langrehr JM; Neuhaus P; Dietel M; Pilarsky C
    Clin Cancer Res; 2006 Nov; 12(21):6444-51. PubMed ID: 17085658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival.
    Davidson B; Hadar R; Stavnes HT; Trope' CG; Reich R
    Hum Pathol; 2009 May; 40(5):705-13. PubMed ID: 19157507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of peroxisome proliferator-activated receptor gamma in salivary duct carcinoma: immunohistochemical analysis of 15 cases.
    Mukunyadzi P; Ai L; Portilla D; Barnes EL; Fan CY
    Mod Pathol; 2003 Dec; 16(12):1218-23. PubMed ID: 14681322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 15-Lipoxygenase-2 gene regulation by its product 15-(S)-hydroxyeicosatetraenoic acid through a negative feedback mechanism that involves peroxisome proliferator-activated receptor gamma.
    Subbarayan V; Krieg P; Hsi LC; Kim J; Yang P; Sabichi AL; Llansa N; Mendoza G; Logothetis CJ; Newman RA; Lippman SM; Menter DG
    Oncogene; 2006 Sep; 25(44):6015-25. PubMed ID: 16682954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of peroxisome proliferator-activated receptor in histologically different human gastric cancer tissues.
    Nomura S; Nakajima A; Ishimine S; Matsuhashi N; Kadowaki T; Kaminishi M
    J Exp Clin Cancer Res; 2006 Sep; 25(3):443-8. PubMed ID: 17167986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor gamma and growth inhibition by its ligands in uterine endometrial carcinoma.
    Ota K; Ito K; Suzuki T; Saito S; Tamura M; Hayashi S; Okamura K; Sasano H; Yaegashi N
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4200-8. PubMed ID: 16857792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of peroxisome proliferator-activated receptor gamma, E-cadherin and matrix metalloproteinases-2 in gastric carcinoma and lymph node metastases.
    He Q; Chen J; Lin HL; Hu PJ; Chen MH
    Chin Med J (Engl); 2007 Sep; 120(17):1498-504. PubMed ID: 17908458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor gamma regulates E-cadherin expression and inhibits growth and invasion of prostate cancer.
    Annicotte JS; Iankova I; Miard S; Fritz V; Sarruf D; Abella A; Berthe ML; Noël D; Pillon A; Iborra F; Dubus P; Maudelonde T; Culine S; Fajas L
    Mol Cell Biol; 2006 Oct; 26(20):7561-74. PubMed ID: 17015477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor-gamma and growth inhibition by its ligands in prostate cancer.
    Nagata D; Yoshihiro H; Nakanishi M; Naruyama H; Okada S; Ando R; Tozawa K; Kohri K
    Cancer Detect Prev; 2008; 32(3):259-66. PubMed ID: 18789607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor-gamma and retinoid X receptor-alpha expression in pancreatic ductal adenocarcinoma: association with clinicopathological parameters, tumor proliferative capacity, and patients' survival.
    Giaginis C; Katsamangou E; Tsourouflis G; Zizi-Serbetzoglou D; Kouraklis G; Theocharis S
    Med Sci Monit; 2009 May; 15(5):BR148-56. PubMed ID: 19396032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of peroxisome proliferator-activated receptor-gamma in human pituitary adenomas and its correlation to tumor invasiveness].
    Huang CX; Hou YH; Zhao JN; Wang YT; Li JJ; Wen L
    Ai Zheng; 2008 Jun; 27(6):590-4. PubMed ID: 18570731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-6 and PPARgamma signalling in human PC-3 prostate cancer cells.
    Pitulis N; Papageorgiou E; Tenta R; Lembessis P; Koutsilieris M
    Anticancer Res; 2009 Jun; 29(6):2331-7. PubMed ID: 19528499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study of rosiglitazone therapy in women with breast cancer: effects of short-term therapy on tumor tissue and serum markers.
    Yee LD; Williams N; Wen P; Young DC; Lester J; Johnson MV; Farrar WB; Walker MJ; Povoski SP; Suster S; Eng C
    Clin Cancer Res; 2007 Jan; 13(1):246-52. PubMed ID: 17200362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of peroxisome proliferator-activated receptor-gamma expression in human eosinophils by estradiol.
    Ueki S; Oguma M; Usami A; Kamada Y; Kato H; Kamada R; Takeda M; Ito W; Tanigai T; Kayaba H; Chihara J
    Int Arch Allergy Immunol; 2009; 149 Suppl 1():51-6. PubMed ID: 19494505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine differentiation in stage D2 prostate cancers.
    Kamiya N; Suzuki H; Kawamura K; Imamoto T; Naya Y; Tochigi N; Kakuta Y; Yamaguchi K; Ishikura H; Ichikawa T
    Int J Urol; 2008 May; 15(5):423-8. PubMed ID: 18452460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of the peroxisome proliferator-activated receptor gamma in the immune system of weaned pigs after Escherichia coli lipopolysaccharide injection.
    Liu Y; Lu J; Shi J; Hou Y; Zhu H; Zhao S; Liu H; Ding B; Yin Y; Yi G
    Vet Immunol Immunopathol; 2008 Jul; 124(1-2):82-92. PubMed ID: 18394717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.